FSD Pharma Inc. (formerly, Century Financial Capital Group Inc., the “Corporation”) announced that it has completed its previously announced business combination with FV Pharma Inc. (“FV Pharma”). On March 9, 2018, the Corporation and FV Pharma entered into an arm’s length definitive business combination agreement (the “Business Combination Agreement”) with 2620756 Ontario Inc. (“SubCo”), a wholly-owned subsidiary of the Corporation, incorporated for the purpose of this transaction. Pursuant to the Business Combination Agreement, the Corporation changed its name to FSD Pharma Inc. and completed a business combination with FV Pharma by way of a three-cornered amalgamation pursuant to which FV Pharma amalgamated with SubCo (the “Transaction”). The resulting amalgamated corporation carried on in the name of FV Pharma as a wholly-owned subsidiary of the Corporation. Following the completion of the Transaction, FSD Pharma Inc. will carry on the medical cannabis business of FV Pharma. For the purposes of this press release, the term “Resulting Issuer” means the Corporation following completion of the Transaction.

Hemp Land, Cannabis Hemp Blog, 04/13/2022 05:38:00

Open article: https://hempland.net/fsd-pharma-announces-closing-of-business-combination-and-conditional-approval-from-the-cse/